| Oncolytic viruses: a new class of immunotherapy drugs HL Kaufman, FJ Kohlhapp, A Zloza Nature reviews Drug discovery 14 (9), 642-662, 2015 | 1499 | 2015 |
| Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges PG Rubinstein, DM Aboulafia, A Zloza Aids 28 (4), 453-465, 2014 | 265 | 2014 |
| Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response S Wood, V Jayaraman, EJ Huelsmann, B Bonish, D Burgad, ... PloS one 9 (3), e91574, 2014 | 239 | 2014 |
| Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer JH Newman, CB Chesson, NL Herzog, PK Bommareddy, SM Aspromonte, ... Proceedings of the National Academy of Sciences 117 (2), 1119-1128, 2020 | 154 | 2020 |
| Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease E Hahm, C Wei, I Fernandez, J Li, NJ Tardi, M Tracy, S Wadhwani, Y Cao, ... Nature medicine 23 (1), 100-106, 2017 | 154 | 2017 |
| Oncolytic viruses—natural and genetically engineered cancer immunotherapies SR Jhawar, A Thandoni, PK Bommareddy, S Hassan, FJ Kohlhapp, ... Frontiers in Oncology 7, 202, 2017 | 145 | 2017 |
| First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors MN Stein, JR Bertino, HL Kaufman, T Mayer, R Moss, A Silk, N Chan, ... Clinical cancer research 23 (15), 4163-4169, 2017 | 143 | 2017 |
| Mutant HSP70 reverses autoimmune depigmentation in vitiligo JA Mosenson, A Zloza, JD Nieland, E Garrett-Mayer, JM Eby, ... Science translational medicine 5 (174), 174ra28-174ra28, 2013 | 124 | 2013 |
| MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation PK Bommareddy, S Aspromonte, A Zloza, SD Rabkin, HL Kaufman Science translational medicine 10 (471), eaau0417, 2018 | 114 | 2018 |
| CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus MH Faridi, SQ Khan, W Zhao, HW Lee, MM Altintas, K Zhang, V Kumar, ... The Journal of clinical investigation 127 (4), 1271-1283, 2017 | 104 | 2017 |
| Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study HL Kaufman, T Amatruda, T Reid, R Gonzalez, J Glaspy, E Whitman, ... Journal for immunotherapy of cancer 4, 1-8, 2016 | 103 | 2016 |
| Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma PK Bommareddy, A Zloza, SD Rabkin, HL Kaufman Oncoimmunology 8 (7), e1591875, 2019 | 99 | 2019 |
| HSP70i is a critical component of the immune response leading to vitiligo JA Mosenson, A Zloza, J Klarquist, AJ Barfuss, JA Guevara‐Patino, ... Pigment cell & melanoma research 25 (1), 88-98, 2012 | 97 | 2012 |
| Active β-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells A Kumar, A Zloza, RT Moon, J Watts, AR Tenorio, L Al-Harthi Journal of virology 82 (6), 2813-2820, 2008 | 92 | 2008 |
| Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses CB Chesson, EJ Huelsmann, AT Lacek, FJ Kohlhapp, MF Webb, ... Vaccine 32 (10), 1174-1180, 2014 | 86 | 2014 |
| CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T … A Zloza, YB Sullivan, E Connick, AL Landay, L Al-Harthi Blood 102 (6), 2156-2164, 2003 | 77 | 2003 |
| NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses A Zloza, FJ Kohlhapp, GE Lyons, JM Schenkel, TV Moore, AT Lacek, ... Nature medicine 18 (3), 422-428, 2012 | 70 | 2012 |
| Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment J Wagner, CL Kline, L Zhou, KS Campbell, AW MacFarlane, AJ Olszanski, ... The Journal of clinical investigation 128 (6), 2325-2338, 2018 | 67 | 2018 |
| Enhancing the magnitude of antibody responses through biomaterial stereochemistry R Appavu, CB Chesson, AY Koyfman, JD Snook, FJ Kohlhapp, A Zloza, ... ACS Biomaterials Science & Engineering 1 (7), 601-609, 2015 | 66 | 2015 |
| NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade FJ Kohlhapp, JR Broucek, T Hughes, EJ Huelsmann, J Lusciks, JP Zayas, ... Journal for immunotherapy of cancer 3, 1-13, 2015 | 65 | 2015 |
Jason M SchenkelMD Anderson Cancer CenterVerified email at mdanderson.org
